chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was breastfeeding my 3 month old at the time I received my vaccine, and immediately after receiving my second does my milk supply stopped abruptly. Following that I had my first menstrual cycle since I had been pregnant within one week of receiving the dose. My cycle since then then has been abnormal, large amounts of bleeding and extended amounts of time of bleeding between cycles. I have had ultrasounds and blood work to confirm that there are no uterine issues from the pregnancy or hormone imbalances that should be causing these abnormalities. I have never had these issues in the past even after my first pregnancy in 2016. Additionally, I have had a lump in my left breast since receiving the second vaccine dose and have had extensive imaging and reporting that I have inflammation in my auxiliary lymph node from the vaccine that has not gone down in size since May 2021.
Prior to the Covid vaccine, periods were very regular, generally lasting 28 days, severe cramps the first day, treated with Motrin, then bleeding lasting 6 days, moderate flow.  May 1 (day 1), cycle lasted 26 days with regular bleeding and regular weekly symptoms.  July 27 (day 1), cycle lasted 28 days with regular bleeding and regular weekly symptoms.  June 24, cycle lasted 23 days, nearly a week early. Irregular weekly symptoms including irregular estrogen surges (causing anger, sleep disturbances, anxiety and depression), and NO severe cramping on July 17 (day 1 of next cycle). I described the weekly symptoms to my parents as "weird."
Started with an UTI which I got medication. I caught a very bad cold. I got this from my husband, and he came down with it two days before I got vaccinated. The coughing is not lungs, loss of energy, loss of taste and smell. I slowly got better which took over a week. I was also being evaluated at the same time for spinal stenosis. I did not have a lot of nasal congestion. It was just different than other colds I have had.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 26-MAR-2015, the patient was vaccinated with improperly stored MMR II lot # K008814 and 19-JUN-2016 (unknown strength and route). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Employee received influenza vaccine on 10/2/07 at work.  Developed rash in afternoon on 10/3/07.  Went to local hospital's emergency room on 10/4/07, received rx for Medrol dosepak, but did not have it filled because employee was feeling better.  Went to emergency room again on 10/6/07 and was given IV diphenhydramine.  Symptoms included hives, itching, lip swelling, mild shortness of breath.
Large, red, oval discoloration below injection site in arm. Hot, itchy, raised, can feel large lump under site.  Day two, lump has gone down, itching has subsided, redness remains.
Upon injection vaccine squirt out of cracked syringe. Patient only received 0.1 CC, 50 a full dose was administered following event. Pharmacy and POD Director notified.
Initial report was received from a consumer on 31 May 2013, who is also the patient. An 81-year-old male patient received the first doses of following vaccinations on 07 March 2013: IMOVAX Rabies (Sanofi Pasteur), Tetanus Toxoid (Manufacturer unknown), and Rabies Immunoglobulin (Manufacturer unknown) (lot numbers were unknown, route and site of administration were not reported). The patient had wound from a cat bite and scratches. The patient had 3 more IMOVAX vaccinies, but did not have dates of vaccinations. An unreported amount of time later, the patient stated his wound infection was worse, he had nasal and throat mucous, "frothy" mucous from the mouth, exacerbation of an old whiplash injury, and worsening of paralysis from a previous stroke. The patient had paralysis of lower extremities and now has paralysis of the entire right side. The patient had his "lung fluke" condition worsen. The patient believed the "rabies vaccine didn't work" but he had not been able to have titers ordered by a healthcare provider. He received healthcare through the hospital. He had seen his doctor in the past for his "lung fluke condition." The patient's allergies included "lyserine cream" for a skin rash. The patient had a history of numerous medical conditions such as history of past stroke, radiation sickness, numerous "infections", and lung fluke condition. The patient had no illness at the time of vaccination and no other vaccinations within 4 weeks of vaccinations given 07 March 2013. The patient's status was reported as not recovered. Documents held by sender: None.
DIZZINESS; CHILLS; FEVER; MUSCLES ACHES; HEADACHE; This spontaneous report received from a patient concerned a 49 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy. The patient experienced drug allergy when treated with codeine, and sulfamethoxazole/trimethoprim. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on right arm on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100 F. On 31-MAR-2021 18:00, the subject experienced dizziness. On 31-MAR-2021 18:00, the subject experienced chills. On 31-MAR-2021 18:00, the subject experienced fever. On 31-MAR-2021 18:00, the subject experienced muscles aches. On 31-MAR-2021 18:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on APR-2021, and had not recovered from muscles aches, headache, and dizziness. This report was non-serious.
HBV #1 given on 10/11/2003 in afternoon.  Approximately 1.5-2 hours later, patient started to chill, felt flushed and had to go to bed.  Woke up throughout the night sweating and intermittently chilling.  Unable to get out of bed except for short period of time.  Felt fine in AM.
strong headache, strong vomiting, fatigue (was not able to get up all day) the day after the vaccine  no treatment.  felt better two days later
Itching of injection site; Fever; Redness and swelling of injection site; Redness and swelling of injection site; Severe fatigue; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 28Apr2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and chronic migraines. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vortioxetine hydrobromide (TRINTELLIX), lurasidone hydrochloride (LATUDA), ethinylestradiol/norgestimate (TRI-SPRINTEC) and modafinil (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 03Apr2021 at 14:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 11:30, on the day of injection, the patient experienced redness and swelling of injection site, severe fatigue and headache. On 29Apr2021, day after injection, the patient experienced fever, severe headache, redness and swelling of injection site. On 30Apr2021, two days after injection, the patient experienced mild headache, redness, swelling, and itching of injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events redness and swelling of injection site, severe fatigue and headache, fever and itching of injection site was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 22Mar2022 as dose 4 (booster), single (Lot number: 04C21A) at the age of 67 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: other medical history: Asthma; "Known allergies: Sulfa drugs" (unspecified if ongoing), notes: Known allergies: Sulfa drugs. The patient took concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: Patient received other vaccines and Other medications in 2 weeks.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication were not reported. On unknown dates, the patients were vaccinated with doses of LIQUID PEDVAXHIB injection, lot # K008681, expiration date 13-MAR-2017 (strength, dose, route and site of administration were not reported), which were exposed to the temperature of 49.1 Fahrenheit degrees for 13.5 hours (cumulative time to the date of reporting). No adverse effect was reported. There were no previous temperature excursions. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Swelling, redness, below arm approximately 3 inches where shot was given rt. arm  Went to Md. Thursday stated infected-physician gave antibiotics.  Pain, body aches and arm pain. Went to MD receieved antibiotic Levaquin 500 mg. q day.  Started 10/16/08. Put cool compress, rest sore arm, Tylenol if needed.  Physician ordered IV anibiotics.  Physician concerned it may be Staph infection, referred to Dr.
Sore arm for that day and then the next morning.; This is a spontaneous report from a contactable physician, the patient. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 16:15 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and hypercholesteremia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Feb2021 at 16:15, the patient experienced sore arm for that day and then the next morning. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm for that day and then the next morning was recovered on an unknown date in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
devel fever w/in an hr p/being immunized; also had chills, vomited x 4-t100 ax; talked w/MD but did not see pt;
Patient stated she needed a first time Pfizer Vaccine. After administration, found in MICR that patient had been vaccinated with Moderna on 5/13/21 and 6/10/21. Patient states never received vaccines.
I FEEL LAZY SINCE THE VACCINATION AND MY JOINT HAVE BEEN HURTING A LOT SINCE THE VACCINATION. I GET MIGRAINES VERY OFTEN
Fever, chills, severe muscle pain, severe lethargy  I took Tylenol
I was hospitalized with covid; I was hospitalized with covid; kind of weak; tired; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 30Mar2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  Last week (unspecified date), she was hospitalized with COVID, just came home after a week in the hospital, just came home last night. She was asking whether she can get the second dose and if there is any guidance on timing of the second dose. She was in the hospital 2 weeks ago and they tested her, and she was negative and last Monday she didn't feel good and went to the hospital and she has COPD and she tested positive on Monday and they kept her. She already has 1 shot and is supposed to get the 2nd on the 24th and she doesn't know if she should wait 14 days. Stated she was kind of weak. She was starting to get tired and not able to complete report. Clarified it was the Pfizer Covid vaccine and she got the 1st dose 30Mar2021 and was due for the 2nd dose 24Apr2021. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on Apr2021 then positive on Apr2021. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Vaccine past due; Second dose after 3 months; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Vaccine past due) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose after 3 months) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 042C20A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Garlic poison iv).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Vaccine past due) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose after 3 months). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Vaccine past due) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose after 3 months) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow up appended
Patient came into the immunization room for his shot along with his mom. He did state he hated needles, but was in good spirits. He got the shot, I filled out his card, and directed him and his mom to sit in the waiting area for 15 mins in case of dizziness or a reaction. They were walking out of the room to the waiting area and he almost immediately fainted. He fell and possibly hit his head on the chair/ floor when he went down. (This was maybe 2 mins post-injection). He almost looked like he was going to have a seizure (arms were tensed up, his eyes were not focused, was starting to shake) but then he suddenly came-to. He seemed to be pretty coherent after he woke back up but 911 was called since he was bleeding
I believe I was exposed to COVID-19 on July 8th. Began experiencing symptoms on July 12th early in the morning. I had a sore throat, sinus pressure, headache, and fatigue. I thought I was developing a sinus infection but tested positive on an at home test at the insistence of a friend. Symptoms persisted and I developed fever and chills. I felt as if I had a horrible case of flu. Went to urgent clinic on July 14th and was prescribed Paxlovid.  After the second dose I began feeling much better. The medication resolved all of my symptoms but fatigue which lasted about a month. I also began experiencing increased hair loss after contracting COVID-19.
Difficulty opening my left eye just as I wake up in the morning.  It's scary to have to crank your eye open to see. Then it started happening to the right eye. Then my eyes started feeling dry as well. Over the months I began to have sensations in my cerebrum on the left hemisphere like is was collapsed in a bit, stuck and pulling a bit to the inion area of the cranium but just on the left side. It also feels like the septum is stuck between the hemispheres. I know this is all weird to say but this is how it feels as I track it. Is my CSF fluid drying up in that area? I have this every morning and it is worse on the left side.
G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/1/2022 HTN (HYPERTENSION) I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 2/20/2022 HTN (HYPERTENSION)
No adverse reaction from the vaccine.  The pt. did get COVID 19 and expired from complications of COVID not the vaccine.
At 12:00am on 09/04/2022, about twelve hours after receiving my bivalent booster, I was suddenly hit with extreme chills that caused me to violently shake. After two hours they went away, I fell asleep, and woke up around 2:30am unable to breathe. It did not feel like I was congested, but I did not have any decongestants to take on hand so I couldn't test the theory. I got some breathing ability back after about three hours, but I had marked difficulty breathing until around 11:00am on 09/04/2022. I also developed a red pinpoint rash along the tops of both my left and right thigh. I noticed it first on 09/04/2022 in the early afternoon, but it is possible it appeared overnight. It has taken approximately six days for the rash to dissipate: it is mostly gone as of today, 09/10/22. The rash was not itchy or painful, and there were no other symptoms of an allergic reaction.
This spontaneous report refers received from pharmacist refers to a female patient of unknown age. The patient's drug reactions/allergies were reported for azithromycin, KEFLEX and penicillin. On an unknown date the patient was vaccinated with ZOSTAVX (strength, route not reported). Concomitant therapies included lidocaine, oxycodone, lorazepam, pantoprazole, sertraline hydrochloride, zolpidem tartrate (manufacturer unknown), naproxen and zinc (unspecified). The reporter stated that the patient has had shingles 3 times since receiving the vaccine. The patient was treated with VALTREX for the event. The outcome of shingles is unknown. The patient sought medical attention. Varicella Zoster Virus Identification Program (VZVIP) packet faxed. No product quality complaint was involved. Additional information has been requested.
This spontaneous report was received from a healthcare worker (also reported as office manager) refers to multiple unspecified patients of unknown demographis. No relevant medical history of the patients was reported. On unspecified dates the multiple unspecified patients were vaccinated with (Oka/Merck) VARIVAX (strength, dose, route, site of administration and lot number were not reported). There were no concomitant medications reported. It was reported that the multiple unspecified patients were administered with (Oka/Merck) VARIVAX that was stored improperly on unknown dates. There were no adverse effects reported. It was unspecified whether the patients had sought any medical attention. There was no product quality complaint involved. Follow up information has been received from office manager, who stated she may call back or fax information as it become available. Also, reported that MMR II was not mentioned in the original call, but did experienced a temperature excursion.
Patient received second dose of Pfizer vaccine. Vaccine expiration time 09:30 on 5/12/2021. Patient received vaccine on 5/12/2021 at 09:33. MD made aware. No harm to patient or adverse reactions.
This spontaneous report was received from other refers to a patient of unknown age and gender. No pertinent medical history was reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route and lot# were not reported). No concomitant therapies were reported. On an unknown date, the patient experienced injection site reaction to ZOSTAVAX. She experienced injection site erythema, injection site hard to the touch, injection site swelling and injection site pruritus. No Product Quality Complaint (PQC) was involved. Action taken was unknown. The outcome of events were unknown. The reporter did not provide the causality between the event and the suspect therapy. Additional information has been requested.
Starting a few days after injection tongue felt swollen. My mouth felt burned. Improved about 10 days, then happened again: tongue felt swollen, mouth felt like it was burned or had blisters and hives on stomach this time.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly female patient who received SHINGRIX for prophylaxis. In February 2019, the patient received the 1st dose of SHINGRIX. In February 2019, less than a month after receiving SHINGRIX, the patient experienced injection site pain and injection site erythema. On an unknown date, the outcome of the injection site pain and injection site erythema were recovered/resolved. It was unknown if the reporter considered the injection site pain and injection site erythema to be related to SHINGRIX. Additional details were reported as follows: The patient was 70 to 74 years old. The injection occurred prior to interview in February 2019. Market researcher contracted by GSK reported that during an interview, a patient reported pain and redness at the site where she received the SHINGRIX injection. This lasted for several days, but got less severe with each day.
Fever, nausea, aches still existing today, on Oct 16, 2023. I received the Shingrix vaccine at the same time. No problems with severe aches before the vaccinations.
Immediately following the administration of the vaccine, pt had a loss of consciousness @ 1:11pm. Vital signs taken @every 5 minutes. and monitoring of symptoms: lightheadedness, nausea, anxiety.  911 called, EMS assessed pt and pt declined transport to ER for further evaluation. Instructed pt to follow up with primary care MD